LD-2 disclosure · 4th Quarter - Report
MYRIAD GENETICS, INC.
via MYRIAD GENETICS, INC.
Client
- Name
- MYRIAD GENETICS, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- MYRIAD GENETICS, INC.
- Description
- Clinical laboratory
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
Mental health legislation; no draft, no bill introduced - access to genetic testing for mental health treatment decisions Telehealth provisions following PHE; HR 6202/no Senate number - provisions requiring in person visits prior to ordering lab tests
LobbyistsKIMBERLY LINTHICUM
Covered position (KIMBERLY LINTHICUM): Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Section 216(a) of PL 113-93 (Protecting Access to Medicare Act of 2014; aka PAMA) - payment of laboratory tests in Medicare
LobbyistsKIMBERLY LINTHICUM
Covered position (KIMBERLY LINTHICUM): Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
FY22 House and Senate MilCon/VA appropriations (HR 4355); access to depression treatments for veterans